Bone marrow-derived cell therapy after myocardial infarction.
作者信息
Moyé Lemuel A, Simari Robert D, Skarlatos Sonia I
出版信息
JAMA. 2013 Apr 10;309(14):1459. doi: 10.1001/jama.2013.2601.
Abstract
摘要
相似文献
1
Bone marrow-derived cell therapy after myocardial infarction.
JAMA. 2013 Apr 10;309(14):1459. doi: 10.1001/jama.2013.2601.
2
Bone marrow-derived cell therapy after myocardial infarction--reply.
JAMA. 2013 Apr 10;309(14):1459-60. doi: 10.1001/jama.2013.2604.
3
Mixed results for bone marrow–derived cell therapy for ischemic heart disease.
JAMA. 2012 Dec 12;308(22):2405-6. doi: 10.1001/jama.2012.64751.
4
Use of stem cells for ischemic cardiomyopathy--reply.
JAMA. 2013 Apr 10;309(14):1458-9. doi: 10.1001/jama.2013.2893.
5
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321.
6
Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
Circ Res. 2017 May 12;120(10):1598-1613. doi: 10.1161/CIRCRESAHA.117.310599. Epub 2017 Feb 23.
7
PROMETHEUS and POSEIDON: Harnessing the power of advanced cardiac imaging.
Circ Res. 2014 Apr 11;114(8):1222-4. doi: 10.1161/CIRCRESAHA.114.303792.
8
Results from the AHA late-breaking trials on cell-based therapies.
Eur Heart J. 2013 Apr;34(14):1016-7.
9
Use of stem cells for ischemic cardiomyopathy.
JAMA. 2013 Apr 10;309(14):1458. doi: 10.1001/jama.2013.2890.
10
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909.
引用本文的文献
1
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Circ Res. 2014 May 9;114(10):1564-8. doi: 10.1161/CIRCRESAHA.114.303720.
2
Cortical bone-derived stem cells: a novel class of cells for myocardial protection.
Circ Res. 2013 Aug 16;113(5):480-3. doi: 10.1161/CIRCRESAHA.113.302083.
本文引用的文献
1
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA. 2012 Dec 12;308(22):2380-9. doi: 10.1001/jama.2012.28726.
2
Mixed results for bone marrow–derived cell therapy for ischemic heart disease.
JAMA. 2012 Dec 12;308(22):2405-6. doi: 10.1001/jama.2012.64751.
3
Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair.
Circ Res. 2012 Sep 14;111(7):854-62. doi: 10.1161/CIRCRESAHA.112.265678. Epub 2012 Jul 19.
4
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA. 2012 Apr 25;307(16):1717-26. doi: 10.1001/jama.2012.418. Epub 2012 Mar 24.
5
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.
J Am Coll Cardiol. 2012 Mar 6;59(10):942-53. doi: 10.1016/j.jacc.2011.11.029.
6
Stem cell treatment for acute myocardial infarction.
Cochrane Database Syst Rev. 2012 Feb 15(2):CD006536. doi: 10.1002/14651858.CD006536.pub3.
7
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA. 2011 Nov 16;306(19):2110-9. doi: 10.1001/jama.2011.1670. Epub 2011 Nov 14.
8
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
N Engl J Med. 2006 Sep 21;355(12):1210-21. doi: 10.1056/NEJMoa060186.
Zotero 插件